Author

Ron Farkas

Observed name: RON FARKAS

Institution: Apnimed (United States)

Observed institution: Apnimed (United States)

OpenAlex ID: A5062895480

Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy)

2026 · Patrick J Strollo, Ron Farkas, et al. · American Journal of Respiratory and Critical Care Medicine · 17

Aroxybutynin and atomoxetine (AD109) for the treatment of obstructive sleep apnea: Rationale, design and baseline characteristics of the phase 3 clinical trials

2025 · Luigi Taranto-Montemurro, Sanjay R. Patel, et al. · Contemporary Clinical Trials Communications · 10

The Lunairo Trial: a 51-week Phase 3, Randomized, Double-blind, Placebo-controlled Study of Aroxybutynin and Atomoxetine (ad109) in Obstructive Sleep Apnea

2025 · SANJAY PATEL, RON FARKAS, et al. · CHEST Journal · 5

The Synairgy Trial: a 26-week Phase 3, Randomized, Double-blind, Placebo-controlled Study of Aroxybutynin and Atomoxetine (ad109) in Obstructive Sleep Apnea

2025 · PATRICK J STROLLO, RON FARKAS, et al. · CHEST Journal · 4

0464 The Impact of Fatigue and Sleepiness on Patients with OSA: A Closer Look with Patient Reported Outcome Measures

2024 · Helene Emsellem, Hilary Colwell, et al. · SLEEP · 1

Content validity and clinically meaningful change on patient-reported outcome measures for use in obstructive sleep apnea

2026 · Joseph M. Ojile, Kristina S. Yu, et al. · Sleep Medicine

0589 Concomitant Aroxybutynin and Atomoxetine (AD109) with GLP-1 Agonists: An Analysis of the SynAIRgy and LunAIRo Trials in Obstructive Sleep Apnea

2026 · Patrick Strollo, Huy Pho, et al. · SLEEP

0672 Pharmacokinetics, Efficacy, and Safety of AD109 (Aroxybutynin and Atomoxetine) in Participants with Obstructive Sleep Apnea and Obesity Taking a GLP-1

2026 · Hsuan-Ming Yao, Laura Gell, et al. · SLEEP

0656 Psychometric Validation of the PROMIS Fatigue 8a, PROMIS Sleep Impairment 8a and ESS in Adults with Mild to Severe Obstructive Sleep Apnea

2026 · Kristina Yu, Shauna McManus, et al. · SLEEP

0679 Aroxybutynin and Atomoxetine (AD109) and Patient-Reported Outcomes: A Pooled Analysis of the SynAIRgy and LunAIRo Trials in Obstructive Sleep Apnea

2026 · Patrick Strollo, Douglas Kirsch, et al. · SLEEP

0663 Content Validity and Meaningful Change on Patient-Reported Outcome Measures for Use in Obstructive Sleep Apnea

2026 · Joseph Ojile, Kristina Yu, et al. · SLEEP

Real-world Incremental Economic Burden of Fatigue and Daytime Sleepiness in Newly Diagnosed Patients With Obstructive Sleep Apnea in the Medicare Population

2025 · KRISTINA YU, NATHANIEL WATSON, et al. · CHEST Journal

A response to "Single-session treatment: A counseling paradigm for school psychology"

2006 · Ron Farkas · PsycEXTRA Dataset

Works count: 13

Citation count: 37

H-index: 4

I10-index: 2